1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Macular Edema Global Clinical Trials Review, H1, 2015

Macular Edema Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 111 pages

Macular Edema Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Macular Edema Global Clinical Trials Review, H1, 2015" provides data on the Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Macular Edema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Macular Edema. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Macular Edema Global Clinical Trials Review, H1, 2015
Introduction 6
Macular Edema 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Macular Edema 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Macular Edema Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Allergan, Inc. 32
Clinical Trial Overview of Allergan, Inc. 32
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
Regeneron Pharmaceuticals, Inc. 39
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Merck and Co., Inc. 41
Clinical Trial Overview of Merck and Co., Inc. 41
Eyetech Pharmaceuticals, Inc. 42
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 42
Bayer AG 43
Clinical Trial Overview of Bayer AG 43
Clearside BioMedical, Inc. 44
Clinical Trial Overview of Clearside BioMedical, Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
National Eye Institute 45
Clinical Trial Overview of National Eye Institute 45
Johns Hopkins University 46
Clinical Trial Overview of Johns Hopkins University 46
Shahid Beheshti University of Medical Sciences 47
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 47
Assistance Publique - Hopitaux de Paris 48
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 48
Queen's University 49
Clinical Trial Overview of Queen's University 49
Kagoshima University 50
Clinical Trial Overview of Kagoshima University 50
Wills Eye Institute 51
Clinical Trial Overview of Wills Eye Institute 51
Yamagata University Hospital 52
Clinical Trial Overview of Yamagata University Hospital 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Johann Wolfgang Goethe University Hospitals 54
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 54
Five Key Clinical Profiles 55
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 111

List of Tables

Macular Edema Therapeutics, Global, Clinical Trials by Region, 2015* 7
Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Macular Edema Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Macular Edema Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Macular Edema Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 32
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 39
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 40
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 41
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015* 42
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 43
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Clearside BioMedical, Inc., 2015* 44
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 45
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 46
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 47
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 48
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 49
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagoshima University, 2015* 50
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Wills Eye Institute, 2015* 51
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Yamagata University Hospital, 2015* 52
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 53
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2015* 54

List of Figures

Macular Edema Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Macular Edema Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 110

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.